(Total Views: 176)
Posted On: 06/03/2022 2:45:51 PM
Post# of 124479
$IMMP News Article - Immutep Reports Positive Overall Response Rate in its Phase II Clinical Trial in 1st line NSCLC for PD-L1 All-Comers https://marketwirenews.com/news-releases/immu...24847.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
